Therapeutics: MicroRNA-186-5p (miR-186-5p); chemokine CXC motif ligand 13 (CXCL13); CXC chemokine receptor 5 (CXCR5)

Neurology

INDICATION: Pain

Mouse studies suggest promoting miR-186-5p expression or inhibiting CXCL13-CXCR5 signaling could help

Read the full 138 word article

User Sign In